A PROJECT REPORT ON

“A STUDY TO UNDERSTAND THE PRESCRIPTION PATTERN OF

GENERIC DRUGS”
FOR
EMTREAT PHARMACEUTICALS Pvt. Ltd, AKOLA

SUBMITTED BY
Mr. NANDU R. KUMBHARE
BATCH: 2017-19

UNDER THE GUIDENCE OF

Dr. NITU SAXENA

SUBMITTED TO
SAVITRIBAI PHULE PUNE UNIVERSITY
In the partial fulfillment of the requirements for the award of
Masters in Business Administration (MBA)

Through

Dr. D. Y. PATIL UNITECH SOCIETY’S

Dr. D. Y. Patil Institute of Management & Research,
SantTukaram Nagar, Pimpri, Pune
Pune- 411018
1
 DECLARATION

I the undersigned hereby declare that project report titled “A STUDY TO

UNDERSTAND THE PRESCRIPTION PATTERN OF GENERIC DRUGS” which has
been submitted by me to Savitribai Phule Pune University, in partial fulfillment of
requirement for the award of degree of Master of Business Administration under the
guidance of Dr. Nitu Saxena (Internal guide) Mr.Abhay Palsodkar Domestic Head of
Sales(external guide), is an original work of the undersigned and not been reproduced
from any other source.

Signature:

Mr. NANDU R. KUMBHARE

Date:

Place:

2
 ACKNOWLEDGEMENT

I would like to express my sincere gratitudeto Mr. AbhayPalsodkar (Sales Manager

Domestic) who gave me a chance to be a part such a Prestigious Organization And
givena constant encouragement for the completion of this project report.

I also acknowledge my deep sense of gratitudeto Dr. Rakesh Dholakia,Director, Dr. D.

Y. Patil Institute of Management & Research for allowing me to carry out this project
work.

I wish to owe my sincere thanks to my Project Guide Dr. NituSaxena(Faculty

DYPIMR), for their able guidance and usefulsuggestions which helped me in completing
the project work.

I would also like to express my heartfelt thanks to my brother Mr. KishorWarudkar for
their help and wishes for thesuccessful completion of the project.

Finally I owe my regards to all those who supported & helped me in any respect
directlyor indirectly during the tenure of this project.

Mr. NANDU RAMESHRAO KUMBHARE

3
 EXECUTIVE SUMMARY

The project "A STUDY TO UNDERSTAND THE PRESCRIPTION PATTERN OF

GENERIC DRUGS" was undertaken as part of academic requirement of SIP MBA-
Marketing course and was conducted for EMTREAT PHARMACEUTICALS
PRIVATE LIMITED. Emtreat Pharmaceuticals Private Limited is an unlisted private
company. Emtreat Pharmaceuticals Private Limited is a marketing company they are
doing marketing of drug like, Puretel, Glimtreat, Pantreat, Ekast, Ementin&Vtreat etc.
Hindustan Antibiotics Limited (HAL) is the first drug manufacturing company to be set
up in the public sector by Government of India with active co-operation of WHO and
UNICEF, HAL is the first drug manufacturing unit in India to undertake commercial
production of antibiotics like Penicillin, Streptomycin, Gentamicin, Ampicillin
&Amoxicillin etc.

The project objectives are as follows:

A. To study the awareness of Generic Drugs amongst Doctors, Chemists &

Distributors.

B. To understand the perception of Doctors, Chemists & Distributors towards

Generic Drugs & Prescription Pattern of Generic Drugs.

C. To carry out Comparative analysis of Generic drugs & Branded Drugs.

The sample size of 165 doctors including BAMS, MBBS & MD – Who are
participating in Amravati Districts, 128 chemists& 56 Distributor’s are constituted for the
study.

The Major findings of the study were:

82% doctors believe that generic drugs are safe as branded drugs.
73 % doctors allow generic drugs to be substitute for branded drugs.
71% doctors feel that generic drugs are not differ from FDA standards.
4
More than 91% chemist store generic drugs & 86% chemist receive Prescription
for genericdrugsweakly.
According to doctors patients can save more than 50% money by taking generic
drugs.
69% doctors feel that Prescription will not affect by free samples which are given
by MR.
According to 53% distributors, average demand for generic drugs is 25 – 50%.
More than 77% chemist & 53% distributors‘ feels that due to low cost of generic
drugs it will not affect sell of branded drugs.

5
 TABLE OF CONTENT

CHAPTER TITLE PAGE NO.

NO.

Executive summary

1 Introduction 01-08

2 Company profile 09-11

3 Theoretical Background 12-13

4 Research methodology 14-18

5 Data collection and Analysis 19-48

6 Observation and Findings 49

7 Suggestions/ Recommendation 50

8 Conclusion 51

9 Annexure 52-57

Bibliography 58-59

6
INTRODUCTION

7
 1. INTRODUCTION

1.1 INTRODUCTION TO THE PROJECT:

Project location: - Amravati district:- Amravati District is a district in Maharashtra

stateof India. Amravati is a administrative headquarters of the district. The district is
bounded by Betul District of Madhya Pradesh state of the north, and by the Maharashtra
district of Nagpur the district consists of six sub-divisions, which are further divided into
14 talukas. Amravati sub- division is divided into three talukas.

Demographics:-According to the 2011 census Amravati District has a population of

2,887,826 527 roughly equal to the nation of Jamaica or the US state of Arkansas. This
gives it a ranking of 131st in India (out of a total of 640). The district has a population
density of 237 inhabitants per square kilometer (610 /sq mi). Its population growth rate
over the decade 2001-2011 was 10.77%. Amravati has a sex ratio of 947 females for
every 1000 males, and a literacy rate of 88.23%.

GENERIC DRUGS:
A generic drug is identical - or bioequivalent -- to a brand name drug in dosage form,
safety, strength, route of administration, quality, performance characteristics and intended
use. Although generic drugs are chemically identical to their branded counterparts, they
are typically sold at substantial discounts from the branded price. The determination of
drug approval is made according to whether it is pharmaceutically equivalent, bio-
available, and bioequivalent. World Health Organization (WHO) provided a definition
for counterfeit drugs. After the patent is over, the same drug can be copied by anybody
and the costs reduce drastically. Many of the anti-diabetic, antihypertensive and antibiotic
drugs are available now as Generic formulations.[1]

After the expiry of patent of the patented drug, generic drugs are marketed. Generic drugs
are available at affordable prices with maintaining quality. These Generic formulations
balance public interest as critical disease like cancer, AIDS etc. Brand name and generic
versions of medicines like high blood pressure, diabetes, etc. Today about 50% of all
prescriptions are filled generic drugs. The FDA has established standards for generic
8
drugs that might seem complicated but are really simple.
The most important advantage with generic drugs is less expensive than the branded
versions. They are cheaper as no R & D investments are involved as in the case of
branded or new drug. Generic manufacturers are able to sell their products for lower
prices because they are not required to repeat the costly clinical trials of new drugs and
generally do not pay for costly advertising, marketing, and promotion. In addition,
multiple generic companies are often approved to market a single product; this creates
competition in the market place, often resulting in lower prices. So Generics can cost
between 20 and 80 percent less. [2]

According to the FDA, to substitute a generic for brand name drug must follow
followingcriteria - It must contain the same active ingredients (the chemical substance
that makes the drug work), the same dosage strength (the amount of active ingredients,
for example 20 mg or 40 mg), the same dosage form (that it, it needs to be available in
the same form as the original – forexample as liquid, pill, etc.), have same route of
administration (the way the medication is introduced into the body)

The generic market reached 100 billion dollar in 2010. The generic growth is three times
higher than the overall growth of drugs. According to expectation of pharmaceutical
industry, percentage of generic drugs in the US market will rise from 14 to 21.[3] This
growth will enhance the export of pharmaceutical products from India will double every
year. In future contribution from the Indian pharmaceutical companies will increase due
to low cost of worker, innovation, recent success in track record in design operation of
high tech manufacturing, testing, quality control, research,clinical testing and
biotechnology.

Availability of Generic drugs in the Indian Market is very low. It is only supplied to
theGovernment and other hospitals or to the physician‘s dispensary. For more profit,
generally branded drugs are promoted to doctors while branded generics are sold at the
Maximum RetailPrice (MRP). But distributor‘s buys branded generic from companies at
the discount of 10-15%of the MRP. In present situation, consumer patients are not

9
benefited and retail chemists earnhuge profit.

Generic Drugs are available all over the world at affordable prices with
maintainingquality. These Generic formulations balance public interest like critical
disease like cancer, AIDS etc. Most nations require generic drug manufacturers to prove
their formulation exhibitsbioequivalence to the innovator product. A number of
developing countries have made use ofcompulsory licensing or government use orders to
enable the supply of more affordable generic drugs in recent years. India today has the
distinction of producing high quality generic medicinesthat are sold around the world.
India tops in the world in exporting generic medicines andcurrently, the Indian
pharmaceutical industry is one of the world's largest and most developed industry.

Basic Generic Drugs Requirement:-[5]

• Same active ingredients

• Same route of administration
• Same dosage form
• Same strength
• Same condition of use
• Inactive ingredient already approved in similar NDA

1.2 GENERIC INDUSTRY

The generic drug industry covers the marketing and sale of medication containing
thesame active ingredients (API's) and dosages as brand-name drugs manufactured by the
pharmaceutical industry. Generic drugs are under the same governance as brand-name
drugs and must adhere to the same standards. When brand-name drugs come off patent,
the market is opened up to generic versions. Patent protection generally protects a drug's
intellectual property rights for about 20 years, but because the patent is effective from the
clinical trial stage.

10
Since the late 1970‘s the substitution of generic drugs for brand name drugs has become a
relatively common physician practice. By the late 1980‘s more than three in
five(62.5%)family physicians ―said they had enough confidence in generic drugs to
prescribe them in their practices, but that only 26.9 percent said they actually prescribed
mostly generics‖ (Bower and Burkett, 1987). At the same time, several studies reported a
connection between physicians’ sources of drug information, their attitudes toward
generics and their prescribing patterns.
By 2003 generic drug prescriptions represented 43 percent of all prescriptions written and
47 percent of new (non-refill) prescriptions Generic drugs were also one of the fastest
growing sectors of the pharmaceutical industry.2 Given the rise in direct-to consumer
advertising, the use of formularies to control costs, and continued concern about drug
safety, it is time to revisit physicians’ opinions and practices regarding generic drug
substitution.[6]
Graph-Leading Companies in the Generic Industry:

Source: new pharma thinkers – TheGeneric Market Industry

GLOBAL GENERIC INDUSTRY:-

The availability of generic drugs will drive demand in developing countries.

Growing middle classes in Asia, the Middle East, and Latin America will seek affordable
versions of the best selling drugs. Central and South American governments are stepping

11
up healthcare efforts and with a growing 65-and-older population, the use of generic
drugs in the region is growing exponentially. Chinese and Indian drug manufacturers
already produce more than 80% of API's used in medication worldwide. With patent
expirations, the production and demand for generic drugs and APIs in China, India, Latin
America, and Central & Eastern Europe is expected to climb.[7]
Teva is the world's biggest generic company and is continuing to climb. During the
course of 2017, Teva launched 18 generics that targeted drugs with 12.2 billion in U.S.
Sales. Teva reported that it accounts for 21.8% of total U.S. Generic prescriptions.[8]Teva
manufactures 71 billion tablets a year in 77 pharmaceutical and API facilities around the
world.
Sandoz is the number two generic company worldwide. It is Novartis' generic unit,
located in Germany with a 7.8 % market share. The company has strong results from the
U.S., Canada,Russia, Italy, Japan, and biosimilars. Sandoz has three strategic priorities:-
1. To be first-to-market as originators' substance patents expire of become unenforceable
2. To be cost competitive by leveraging economics of sale in development and production
3. To differentiate Sandoz based on its extensive global reach and advanced technical
expertise inthe development[9]

An Economic Analysis of Generic Drug Usage:- This independent analysis, conducted

by theIMS Institute.[10]
• The use of generic prescription drugs in place of their brand name Counterparts saved
the health care system more than $931 billion over the past decade.
• In 2010 alone, generic use generated more than $157 billion in savings.
• Savings from newer generic medicines—those that have entered the market
since2001—continue to increase exponentially and account for more than one-third of
the total savings.
[1] - http://www.who.int/trade/glossary/story034/en/
[2] - http://en.wikipedia.org/wiki/Generic_drug
[3] - shopper‘s guide to prescription generic drugs.
[4] - http://blog.oureducation.in/generic-drugs/
[5] - http://www.fda.gov/downloads/Drug/SmallBusinessAssistance/ucm127615.pdf
[6] - (IMS Health, 2004).
[7] - New Pharma thinkers - The Generic Market Industry
[8] & [9] - new Pharma thinkers - The Generic Market Industry

12
INDIAN GENERIC DRUGS INDUSTRY:
India supplies 20% of generic drugs worldwide Posted 01/03/2013. Every fifth
tablet, capsule and injectibles generic drug being used in the world is manufactured in
India, according to India‘s Health Minister Ghulam Nabi Azad.
Being a world leader in generics, India already has a huge presence in the highly
regulated markets in terms of Pharma exports. Almost two thirds of Indian generic
exports are to the highly regulated markets (e.g. the US and Europe), which speaks
volumes about the quality of Indian medicines.
Already this year, India‘s Dr. Reddy‘s, Lupin Labs, Sun Pharma, Ranbaxy and Cipla
have invested over $ 500 million in R&D, which is allowing increased innovation in
manufacturing processes and will ultimately help to lower the cost of medicines
production.[11]

Growth of Generic Drug Industry:-[12]

In future contribution from the Indian pharmaceutical companies will increase due
to low cost of worker, innovation, recent success in track record in design operation of
high tech manufacturing, testing, quality control, research, clinical testing and
biotechnology. Most of the Indian companies have United States Food and Drug
Administration (USFDA) approved plants, about 20% of all Abbreviated New Drug
Applications (ANDA) to the USFDA are field by Indian companies. Now India‘s share of
the generic market is about to 35%. Hence the contribution of the Indian pharmaceutical
industry for the growth of generic drugs in the world is very high.
Over the next few years, an abnormally large number of blockbuster drugs are scheduled
to lose their patent protection, opening the doors to cheaper generic drugs. These drugs
are Blockbuster-brand products and offer tremendous scope to generic manufactures.
In December 2011, Ranbaxy receives approval for the generic Atorvastatin tabletsOf the
original brand name drug Lipitor‘ owned by Pfizer, Inc.
In March 2012, NatcoPharma got compulsory License (CL) for Sorafenib to sylate ofthe
original brand name drug Nexavar owned by Bayer Corp. under the provisions of the
section 84 of the Indian Patent Act 1970. It is used for the treatment of Liver and Kidney
cancer. Its price now Rs 8,800 for 120 tablets (one month‘s therapy) as against Rs.

13
2,84,428 being the cost of Nexavar sold by Bayer Corp.
Growth in the use of generics in India is being encouraged by instructions being issued to
governmental hospitals and doctors to prescribe and to pharmacies to dispense generics to
the maximum extent possible‘.

Availability of Generic drugs in the Indian Market:-[13]

Availability of Generic drugs in the Indian Market is very low. It is only supplied to the
Government and other hospitals or to the physician‘s dispensary. For more profit,
generally branded drugs are promoted to doctors while branded generics are sold at the
Maximum Retail Price (MRP). But distributor‘s buys branded generic from companies at
the discount of 10-15% of the MRP. In present situation, consumer patients are not
benefited and retail chemists earn huge profit.

Exports of generic drugs by Indian Pharma companies:-[14]

India's pharmaceutical industry is gaining its position as a global leader. The
Pharma market in India is expected to touch US$ 74 billion in sales by 2020 from the
current US$ 11 billion, according to a Price water house Cooper (PwC) report.
India has world renowned capacity in producing low cost, high quality bulk and
genericdrugs. The share of Indian Pharma companies in the total pie of approvals for
generic drugs (called abbreviated new drug applications (ANDA) approvals in the US)
has risen steadily. In 2011 itself, more than a third of the ANDA approvals were by
Indian firms. As a consequence, formulation exports from India, essentially generic
drugs, have grown at 21 per cent compounded annual growth rate (CAGR) between
2005-06 and 2010-11. With patents of about US$ 150 billion worth of drugs set to expire
between 2010 and 2015, it is expected that the growth momentum in exports would
continue over the next five years, with exports growing at14-16 per cent CAGR,
[11] - http://www.cci.gov.in/images/media/presentations/ComIssGenPharmIndusIndia_20100401142346.pdf
[12] - international journal of pharmaceutical, chemical and biological sciences
[13] & [14] - www.ijpcbs.com/ THE IMPORTANCE OF GENERIC DRUGS.

14
1.3 OBJECTIVES

The project objectives are as follows:

A. To study the awareness of Generic Drugs amongst Doctors, Chemists & Distributors.

B. To understand the perception of Doctors, Chemists & Distributors towards Generic

Drugs & Prescription Pattern of Generic Drugs.

C. To carry out Comparative analysis of Generic drugs & Branded Drugs.

Scope of the Study:

In today‘s era, the scope of generic drugs is increasing day by day specially in several
illhealth conditions such as diabetes, cardiovascular and in microbial diseases etc. When
any patent expires, new generics are introduced into the market. The scope is also
increased due to Para IVfilings and Bolar provisions. Recently, Para IV filing strategy
has been adopted by leading Indian pharmaceutical companies to introduce generic drug
of its own taking advantage of shortcoming in patent application of patent holders.

According to this, a generic manufacturer challenges the original patented drug and
claims that the generic version proposed to be launched by the manufacturer does not
infringe the patent holder‘s version. In case a patent challenge is won, it entitles the first
to file Para IV generic manufacturer a 180 days exclusivity, if company come up with an
equivalent of the innovator‘s branded formulation. Bolar provision allows generic
manufacturers to prepare and develop regulatory procedures before patent expires, so
that, products are ready for market as soon as the patent ends. With these provisions, in
India, the scope of generic drug manufacturing
has also increased.

15
COMPANY
PROFILE

16
 2. COMPANY PROFILE

2.1Company Profile:

Emtreat Pharmaceuticals Private Limited is an unlisted private company incorporated

on 30 May, 2015. The registered office of the company is at 43A AGRAWAL
LAYOUT, HANUMAN NAGAR LAHAN UMARI, AKOLA, Akola, Maharashtra.

The total paid-up capital is INR 1.00 lac. The company has no reported secured loans.

The last reported AGM (Annual General Meeting) of the company, per our records,
was held on 31 December, 2016. Also, as per our records, its last balance sheet was
prepared for the period ending on 31 March, 2016.

2.2 VITALS:

• CIN: U85191MH2015PTC265085
• INCORPORATION DATE / AGE: 30 May, 2015 / 3 yrs
• LAST REPORTED AGM DATE: 31 December, 2016
• AUTHORIZED CAPITAL: INR 10.0 Lacs
• PAIDUP CAPITAL: INR 1.0 Lacs
• INDUSTRY:Health and Social Work
• TYPE: Unlisted Private Company
• CATEGORY: Company limited by Shares
• SUBCATEGORY: Non-govt company

2.3 Mission:

Emtreat mission is to become a transnational pharmaceutical company through the

development and introduction of a wide portfolio of branded and generic products in
key markets.

2.4 Vision:

17
Emtreat Pharmaceuticals,.is well positioned for growth in the US market. We can
capitalize on the strengths of our parent company Emtreat Limited.

2.5 Company Hierarchy:

The company has 2 directors/key management personnel.

1. Mr. .ARUN OMPRAKASH SHARMA Director

2. Ms. MANGALA ARUN SHARMA Director

2.6 COMPANY PRODUCT PROFILE:-

Sr. BRAND NAME COMPOSITION STRENGTH

No.

1 Puretel Telmisartan 40mg

2 Puretel-AM Telmisartan+Amlodipine 50mg

3 Puretel-CT Telmisartan+Chlorthalido 50mg

ne

4 Glimtreat M1 Glimepiride1mg+Metform 525mg

in

5 Glimtreat M2 Glimepiride2mg+Metform 525mg

in

6 Pantreat Pantoprazole 40mg

7 Pantreat DSR Pantorazole40mg+Dompe 80mg

ridone30mg

8 Ekast-L Levocetrizine5mg+Montel 15mg

ucast10mg

9 Ementin Amoxycillin500mg+Potass 625mg

ium Clavulanate125mg

10 Entefer XT Ferrous 125mg

18
 Ascorbate100mg+Folic
Acid IP 1.1mg

11 Vtreat Multivitamin
Multiminerals
Antioxidant Suspension

12 CalDfine Calcium Citrate

Malate250mg+ Vitamin
D3 1000 IU Tab

19
THEORETICAL
BACKGROUND

20
 3. THEORETICAL BACKGROUND
3.1BACKGROUND OF STUDY

A number of surveys have also shown sizable proportions of patients reporting negative
views about generics, believing them to be less effective, of lower quality and unsuitable
for treatment of major illnesses, as compared to their branded equivalents. Such negative
views of generic medicines are important because they are likely to be associated with
poorer health outcomes due to an association with higher side effect reporting and lower
adherence. If a substantial proportion of doctors, pharmacists and the general population
hold negative views of generic drugs, it could represent an impediment to the widespread
adoption of generic medication.

We conducted a systematic review to examine the attitudes towards generic drugs held by
lay people, doctors and pharmacists. We extracted from the literature the proportion of
participants who held negative views about how generics were perceived compared to
their branded equivalent for the following five perceptions: drug effectiveness, drug
quality, the likelihood of causing side effects, drug safety and attitude towards generic
substitution or the process of replacing a branded medication with its generic equivalent.

REVIEW OF LITERATURE:

Two reviewers (KF and LRM) independently examined the full-text publications to
complete a quality assessment. Raters independently categorized the articles as high,
acceptable or poor quality, based on an evaluation of study design, participants (N, and
type), demographics, recruitment method (random or other), exclusionary criteria,
method of assessing perceptions (interview, questionnaire) and question quality (clarity,
appropriate response options) (see online supplementary appendix 2). Consensus between
the two reviewers was used to resolve any disagreement. Studies that were classified as
being of poor quality were subsequently excluded. In line with Cochrane
recommendations, we chose not to use a standardized scoring system to assess study
quality. Calculating a summary score was not carried out so as to avoid assigning

21
‘weights’ to items on the scale that were unlikely to accurately reflect their relevance and
that may have changed across different studies.

Result of 1322 publications initially identified, 24 were eligible for inclusion. Overall, the
studies revealed that physicians and pharmacists were aware of the cost-saving function
of generic drugs and their role in improving global access to drugs. Nevertheless, marked
differences were observed between countries when studying physicians' and pharmacists'
perceptions of the available generic drugs. In less mature healthcare systems, large
variations regarding, for example, control routines, bioequivalence requirements, and
manufacturer standards were reported. A lack of reliable information and mistrust in the
efficacy and quality were also mentioned by these participants. In the most developed
healthcare systems, the participants trusted the quality of the generic drugs and did not
hesitate to offer them to all patients regardless of socioeconomic status. In general,
pharmacists seemed to have better knowledge of the concept of bioequivalence and
generic drug aspects than physicians.

The aims of this paper were to identify and review the literature on pharmacists' views
and practices on the use of generic medicines. Using appropriate keywords pertaining to
the subject matter, an extensive literature search was undertaken using indexing services
available in the authors' institution library. These electronic databases were searched for
full-text papers written in the English language during the period from 1980 until
September 2007. Based on this search, 13 studies were identified. The majority of studies
are from the United States, with few from Europe and Asia. All retrieved studies, except
one, used quantitative methodology. Most of the studies showed that pharmacists' views
and behaviours towards generic medicine utilisation were affected by economic
considerations, quality and bioequivalency of generic medications, drug therapeutic class,
and other actors (the physicians, the patients, and public health officials). This review
suggests that although in general pharmacists were positively inclined towards generic
medication use, they have some considerations that determine to what extent they will
support generic medicine use. These are economic, scientific, and policy-related
considerations that are likely to remain matters for discussion in the future among
pharmacists and their professional organizations.

22
 RESEARCH
METHODOLOGY

23
 4. RESEARCH METHODOLOGY
WHAT IS RESEARCH?
Research is a logical and systematic search for new and useful information on a
particular topic. Research is done with the help of study, experiment, observation,
analysis, comparison and reasoning. Research is in fact ubiquitous. For example, we
know that cigarette smoking is injurious to health; heroine is addictive; cow dung is a
useful source of biogas; malaria is due to the virus protozoan plasmodium; AIDS
(Acquired Immune Deficiency Syndrome) is due to the virus HIV (Human Immune
Deficiency Virus). How did we know all these? We became aware of all these
information only through research. More precisely, it seeks predictions of events,
explanations, relationships and theories for them.
As stated by Gerald Milburn Scientific research is a chaotic business, stumbling
along administered herrings, errors and truly, creative insights. Great scientific
breakthroughs are rarely the work of a single researchers plodding slowly by inexorably
towards some final goal. The crucial idea behind the breakthrough may surface a number
of times, in different places, only to sink again beneath the babble of an endless scientific
discourse.
One of the most important aspects of research is the statistics associated with it,
conclusion or result. It is about the “thought” that goes behind the research. Research is
conducted with a purpose to understand:

• What do organizations or businesses really want to find out?

• What are the processes that need to be followed to chase the idea?
• What are the arguments that need to be built around a concept?
• What is the evidence that will be required that people believe in the idea or
concept?

RESEARCH DESIGN:A research design is the set of methods and procedures used
in collecting and analyzing measures of the variables specified in the research
problem research. The design of a study defines the study type (descriptive, correlation,
semi-experimental, experimental, review, meta-analytic) and sub-type (e.g. descriptive-

24
longitudinal case study), research problem, hypotheses, independent and dependent
variables, experimental design and, if applicable, data collection methods and a statistical
analysis plan. A research design is a framework that has been created to find answers to
research questions.
This study used descriptive research. Descriptive research involves gathering data that
describe events and then organizes, tabulates, depicts, and describes the data collection. It
often uses visual aids such as graphs and charts to aid the reader inunderstanding the data
distribution and therefore offered a better clarification on online advertising, and
ultimately give a clear picture on the effectiveness and reliability of online advertising
and its relationship to purchase decision.For the purpose of survey, a sample survey was
adopted through the questionnaire and the information gather by the same.

• Descriptive (e.g., case-study, naturalistic observation, survey)

• Correlational (e.g., case-control study, observational study)
• Semi-experimental (e.g., field experiment, quasi-experiment)
• Experimental (experiment with random assignment)
• Review (literature review, systematic review)
• Meta-analytic (meta-analysis)

METHODOLOGY OF STUDY: The primary data for the study was collected by
using a structured questionnaire. The sample size for the study consists of 308
respondents. The questionnaire was prepared in such a way so as to gather data from the
respondents, which will be helpful in attaining the objectives of the study. The collected
data was carefully scrutinized, tabulated and analyzed using simple statistical.

Social research is a scientific method usually applied to social sciences to investigate

human behavior. Social research scientists gather feedback and opinions on critical topics
from their clientele that help them in recognizing areas of improvement according to
human needs. Researchers conduct social experiments using qualitative research methods
such as text analysis, online interviews as well as quantitative research methods such as
statistical analysis via surveys.They implement a balance

25
between qualitative and quantitative research methods to understand how their target
audience operates.

The process of gathering information from a larger population is practically

impossible, which is why researchers and social scientists rely on samples to garner
effective opinions and feedbacks that help them in generalizing it to the entire population.

Research methodology was exploratory in nature

RESEARCH METHOD:

Qualitative Research Methods

Qualitative research is a research method that collects data using conversational methods,
where participants involved in the research are asked open-ended questions. The
responses collected are essentially non-numerical. This method not only helps a
researcher understand “what” participant thinks but also, “why” they think in a particular
way.

Quantitative Research Methods

Quantitative research methods are the methods that deal with numbers and anything that
can be dealt with a measurable form, in a systematic way of investigating the
phenomenon. It is used to answer questions in terms of justifying relationships with
measurable variables to either explain, predict or control a phenomenon.

• Survey Research- The ultimate goal of survey research is to learn about a large
population by deploying the survey. Gone are the days where a survey was carried out
using a pen and a paper. Today, online surveys are a popular mode of research as they are
convenient and can be sent in an email or made available on the internet. In this method,
a researcher designs a survey with most relevant survey questions and deploys the survey.

26
Once the researcher receives the responses he/she summarizes them to tabulate
meaningful findings and data.

POPULATION: The population considered for the study was Doctors, Chemist, &
Distributors.And it is311

RESPONDENTS: Doctors-165, Chemists-128, Distributors-15

SAMPLE:sample is a group of people, objects, or items that are taken from a larger
population for measurement. The sample should be representative of the population to
ensure that we can generalise the findings from the research sample to the population as a
whole.

SAMPLE SIZE: Large sample give more reliable result than small samples.
However it is not necessary to sample the entire target population or even a substantial
portion to achieve reliable result. So, I decided to take the sample size of 308 random
samples from Amravati.

SAMPLING METHODS:Sampling is the process of selecting a representative

group from the population under study. The target population is the total group of
individuals from which the sample might be drawn. A sample is the group of people who
take part in the investigation. The people who take part are referred to as “participants”.

In this study the convenience sampling method was followed.

a) Unit: - The sampling unit used for the study was Doctors, Chemist,& Distributors
b) Sample size :- The sample size was taken by researcher is 308
c) Sampling technique: Simple Random Sampling (Judgmental Sampling)

27
 SOURCES OF DATA COLLECTION:
PRIMARY DATA COLLECTION: In this stage I was collected data through
structured questionnaire given to the Doctors, Chemist & Distributors. Structured
questionnaire used for personal interview also.

SECONDARY DATA COLLECTION: For background information, I used

secondary data from the internet and other related magazines and journals. I also visited
various websites.

DATA COLLECTION TOOL:A structured questionnaire containing open as

well as close ended questions and Structured questionnaire used for personal interview
also. And was recorded on excel and analyze through techniques such as percentage and
represented through bar and pie charts.

Data was recorded on:MS Exceland analyze through techniques such as

percentage and represented through statistical method such as bar and pie charts.

Research region: Amravati district

Duration of research: 2 months

Duration of Data collection: 6 weeks

Duration of project report preparation: 1 month

28
 DATA
COLLECTION
&
ANALYSIS

29
 5. DATA COLLECTION& ANALYSIS

5.1 DATA COLLECTION

In order toA study to understand the prescription pattern of generic drugs with respect to
the doctors chemist and distributors both primary and secondary data will be collected.

Primary Research: Definition

Primary research is defined as a methodology used by researchers to collect data directly,

rather than depending on data collected from previously done research. Technically, they
“own” the data. Primary research is solely carried out to address a certain problem, which
requires in-depth analysis. I have collected primary data through questionnaire.

There are two forms of research:

• Primary Research

• Secondary Research

Businesses or organizations can themselves conduct primary research or can employ a

third party to conduct research on their behalf. One major advantage of primary research
is, this type of research is “pinpointed”, research is carried around only a specific issue or
problem and all the focus is directed to obtain related solutions.

For example, a brand is about to launch a new model of mobile phone and wants to
conduct a research about the looks and features mobile phone they are soon going to
introduce. Organizations can select a qualified sample of respondents that closely
resembles population and conduct primary research with them, to know their opinions.
Based on this research, the brand can now think of probable solutions to make necessary
changes in looks and features of mobile phone.

Primary Research Methods with Examples

30
In this technology-driven world, meaningful data is more valuable than gold.
Organizations or businesses need highly validated data to make informed decisions. This
is the very reason why many companies are proactive to gather their own data so that the
authenticity of data is maintained and they get first-hand data without any alterations.

Here are some of the primary research methods organizations or businesses use to collect
data:

1. Interviews (telephonic or face-to-face): Conducting interviews is a qualitative

research methodto collect data and has been a popular method for ages. These interviews
can be conducted in person (face-to-face) or over the telephone. Interviews are open-
ended method which involves dialogues or interaction between interviewer (researcher)
and interviewer (respondent).

Conducting face-to-face interview is said to generate a better response from respondents

as it is a more personal approach. However, the success of face-to-face interview depends
heavily on researcher’s ability to ask questions and his/her experience related to
conducting such interviews in the past. The types of questions that are used in this type of
research are mostly open ended questions. These questions help to gain in-depth insights
into opinions and perceptions of respondents.

Personal interviews usually last up to 30 minutes or even longer depending on the subject
of research. If a researcher is running short of time conducting telephonic interviews can
also be helpful to collect data.

2. Online surveys: Once conducted with pen and paper, surveys have come a long way
since then. Today, most researchers use online surveys to send it to respondents to gather
information from them. Online surveys are convenient and can be sent on emails or can
be filled out online. These can be accessed on handheld devices like smartphone, tablets,
Ipads and similar devices.

31
Once a survey is deployed, a certain amount of stipulated time is given to respondents to
answer survey questions and send it back to researcher. In order to get maximum
information from respondents, surveys should have a good mix or open ended
questions and close ended questions. Survey should not be lengthy,else respondents lose
interest and tend to leave it half done.

It is a good practice to reward respondents on successfully filling out surveys for their
time and efforts and valuable information. Most organizations or businesses usually
giveaway gift cards from reputed brands that respondents can redeem later.

3. Focus groups: This popular research technique is used to collect data from a small
group of people, usually restricted to 6-10. Focus group brings together people who are
experts in subject matter, for which research is being conducted.

Focus group has a moderator who stimulates discussions among the members to get
greater insights. Organizations and businesses can make use of this method especially to
identify niche market to learn about a specific group of consumers.

4. Observations: In this primary research method, there is no direct interaction between

researcher and person/consumer being observed. Researcher observes the reactions of a
subject and makes notes.

Trained observers or cameras are used to record reactions. Observations are noted in a
predetermined situation. For example, a bakery brand wants to know how people react its
new biscuits, observer notes the first reaction of consumers and evaluates collective data
to draw inference.

Advantages of Primary Research

• One of the most important advantages is, data collected is first hand and is
accurate. In other words, there is no dilution of data. Also, this research method
32
 can be customized to suit personal requirements and needs of organizations or
businesses.
• Primary research focuses mainly on problem in hand, which means entire
attention is directed to find probable solution to a pinpointed subject matter.
Primary research allows researchers to go in depth of a matter and study all
foreseeable options.
• Data collected can be controlled. Primary research gives a means to control how
data is collected and used. It’s up to the discretion of businesses or organizations
who are collecting data how to best make use of data to get meaningful research
insights.
• Primary research is a time-tested method, therefore, one can rely on the results
that are obtained from conducting this type of research.

Disadvantages of Primary Research

• One of the major disadvantages of primary research is, it can be quite expensive
to conduct. One may be required to spend a huge sum of money depending on the
setup or primary research method used. Not all businesses or organizations may
be able to spend a considerable amount of money.
• This type of research can be time-consuming. Conducting interviews, sending and
receiving online surveys can be quite an exhaustive process and need investing
time and patience for the process to work. Moreover, evaluating results and
applying the findings to improve product or service will need additional time.
• Sometimes just using one primary research method may not be enough. In such
cases, use of more than one method is required and this might increase both times
required to conduct research and the cost associated with it.

33
5.2DOCTOR
DOCTOR ANALYSIS

Q.1 QUALIFICATION:
QUALIFICATION:-

Table No. 1
Qualification No. of Dr.
BAMS 95
MBBS 47
MD 23
Grand Total 165

100
BAMS, 94
80

60

40 MBBS, 47

20
MD, 23
0
MD MBBS BAMS

Series1

Fig no. 1
Inference:
In the above graph total 165 doctors are respondents and from that 95 doctors are
BAMS which is 57% of total, 47 doctord are MBBS which is 29% of total, and 23
doctors are MD which is 14% of total

34
Q.2. Do you believe that Generic drugs differ from FDA standards?
Table No. 2
NO 116
YES 48
Grand Total 164

Total
140
116
120

100

80

60 48
40

20

0
YES NO

Fig no. 2
Inference:
71% doctors Believe
lieve that generic drugs arenot differ from FDA standards.
Although the Food and Drug Administration states that generic drugs must be
therapeutically equivalent with brand name drugs, only 29 % doctors believe that
Generic drugs are differ from FDA standards.
Although most brand name drugs cost more than their generic substitutes, the mark-
mark
up on generic drugs is generally more than that on brand name drugs

35
Q.3 Do you allow Generic
eneric drugs to bbe substitute for Branded drugs?

Table No. 3
NO 44
YES 120
Grand Total 164

Total
140
120
120

100

80

60
44
40

20

0
yes NO

Fig no. 3
Inference:

73 % doctors allow generic drugs to be substitute for branded drugs

Only 27 % doctors are not allow generic drugs to be substitute for branded drugs
Approximately one in five doctors believe that some drugs with narrow therapeutic
indices that should not be substituted even when required by third parties, and that
most doctors support the use of generics today.

36
Q.4 Do Patients need influence choi
choice
ce to prescribe Generic over Branded drugs?

Table no. 4
YES 85
NO 79
Grand Total 164

Total
86 85

84

82

80 79

78

76
YES NO

Fig no. 4

Inference:

51 % doctors said that Patients need inf

influence
luence choice to prescribe Generic over
Branded drugs.

48 % doctors says that Patients don‘t need influence

luence choice to prescribe Generic
over Branded drugs.

37
Q.5 - Do you agree that Branded drug Companies are benefitted by givingpatients,
givingpatients
Branded drugs over Generic drugs?

Table No. 5
YES 129
NO 35
Grand Total 164

Total
140 129
120
100
80
60
35
40
20
0
YES NO

Fig no. 5

Inference:

78.66% Doctors agree that Branded drug Companies are benefitted

itted by giving
patients,, Branded drugs over Generic drugs.

21.34 % Doctors don‘t agree that Branded drug Companies are benefitted
benefi by
giving patients with Branded drugs than Generic drugs.

38
Q. 6 Do you feel patients are pressurized with health care plan, by insurance
nsurance companies
totake generic drugs?

Table No. 6

YES 54

NO 110

Grand Total 164

120 110

100

80

60 54

40

20

0
YES NO

Fig no. 6

Inference:

32.93 % doctors feel patients are pressured with health care plan, By Insurance
companies to Take Generic drugs
drugs.

67.07 % doctors come up with this sentence that patients are not pressured with
health care plan, By Insurance companies to Take Generic drugs.

39
Q.7 Branded drugs MR visit regularly and give free samp
samples
les but Generic
drugsrepresentative
epresentative do not give. Does it affect pprescription?

Table No.7

YES 51

NO 113

Grand Total 164

Total
120 113

100

80

60 51
Total
40

20

0
YES NO

Fig no. 7

Inference:

In the above analysis 68% doctors prescription are not affected by free samples
given by branded drugs MR

31% doctors prescription are affected by free samples given by branded drugs
MR.

40
Q. 8 According to you, are Generic drugs as safe and effective as Branded drugs?

Table No. 8
YES 135
NO 29
Grand Total 164

Total
160

140 135

120

100

80
Total
60

40 29

20

0
YES NO

Fig no. 8

Inference:

More than 82% doctors say that Generic drugs are safe and effective as Branded
drugs.

17% doctors feel that Generic drugs are not safe and effective as Branded
Brand drugs.

41
Q.9 How much it will help to the patients to save money, by taking Generic drugs?

Table No. 9

30-50% 35

20-30% 12

>50% 117

Grand Total 164

Total
140

120

100

80

60 72% Total

40

20 35
12
0
30-50% 20-30% >50%

Fig no. 9

Inference:

72% doctors agree that patients can save more than 50% money by taking generic
drugs.

21% doctors agree that patients can save more than 30

30-50%
50% money by taking
generic drugs.

Only 7% doctors agree that patients can save more than 20

20-30%
30% money by taking
generic drugs.

42
Q. 10 Do you purchase or prescribe ggeneric drugs?

Table No. 10
PRESCRIBE 80
PURCHASE 84
Grand Total 164

Total
85
84
84
83
82
81 Total
80
80
79
78
PRESCRIBE PURCHASE

Fig no.10

Inference:

51.22% doctors purchases generic drugs.

48.78% doctors Rx generic drugs.

43
Q. 11- If you Purchase Generic drugs, then how frequently you purchase?

Table No. 11
>3 MONTHS 41
>6 MONTHS 4
NA 79
REGULARLY 40
Grand Total 164

Total
90 79
80
70
60
50 40 41
40 Total
30
20
10 4
0
REGULERILY >3 MONTHS >6 MONTHS NA

Fig no. 11

Inference:

Above 24% doctors regularly purchases generic drugs.

25% doctors purchase generic drugs after every 3 months.

Only 2% doctors purchases generic drugs after every 6 months

44
5.3CHEMIST
CHEMIST ANALYSIS
Q. 12- How many patients visit your store, ddaily?

Table No. 12
0-25 12
25-50 52
50-75 36
75& ABOVE 28
Grand Total 128

Total
60
52
50

40 36

28
30
Total
20
12
10

0
0-25
25 25-50 50-75 75& ABOVE

Fig no. 12
Inference:
From the above graph 12 chemist said that 00-25
25 patients visit their store daily.
52 chemist said that 25
25-50 patients visit their store daily.
36 chemist said that 50
50-75 patients visit their store daily.
28 chemist said that 75&above patients visit their store daily.

45
Q.13- Do you store Generic drugs?

Table No.13

NO 11

YES 117

Grand Total 128

Total
140
117
120

100

80

60 Total

40

20 11

0
NO YES

Fig no. 13

Inference:
More than 91 % chemist
chemists store generic drugs.
Only 9 % chemistss do not store generic drugs.

46
Q. 14 - Do you receive Prescriptions for Generic drugs?

Table No. 14
NO 18
YES 110
Grand Total 128

Total
120 110

100

80

60
Total
40

20 10

0
NO YES

Fig no. 14
Inference:
Above 85 % chemist receive Prescriptions for Generic drugs.
14 % chemist does not receive Prescriptions for Generic drugs.

47
Q. 15 - If yes, then how many prescriptions of Generic drugs you receive, weakly?

Table No. 15
0-20% 12
20-40% 44
40-60% 32
60& ABOVE 24
NA 16
Grand Total 128

Total
50
44
45
40
35 32
30
24
25
20 16 Total
15 12
10
5
0
0-20% 20-40% 40-60% 60& ABOVE NA

Fig no. 15
Inference:
34% chemist receives 20
20-40% prescriptions of generic drugs
25% chemist receives 40
40-60% prescriptions of generic drugs
19% chemist receives 60% & Above prescriptions of generic drugs

48
Q. 16- Do you get discount on purchasing Generic drugs from distributors?

Table No. 16
NO 24
YES 104
Grand Total 128

Total
120
104
100

80

60
Total
40
24
20

0
NO YES

Fig no. 16
Inferences:
More than 81 % chemist get discount on purchasing generic drugs, from distributors.

49
Q. 17 - If yes, how much of discount you get from distributors on purchasingGeneric
drugs?

Table No. 17
0-5% 7
5-10% 31
10-15% 34
15-20% 32
NA 24
Grand Total 128

Total
40
34
35 31 32
30
24
25
20
Total
15
10 7
5
0
0-5% 5-10% 10-15% 15-20% NA

Fig no. 17

50
Q. 18-Is there any effect on taxation in purchase & sale of Generic drugs?

Table No. 18
NO 18
YES 110
Grand Total 128

Total
120 110

100

80

60
Total
40

18
20

0
NO YES

Fig no. 18
Inference:
More than 85% chemist believes that there is effect of taxation on purchasing &
selling of generic drugs.

51
Q.19 - Does Generic drugs due to their lower prices, affects the Sell of branded drugs?

Table No. 19
NO 99
YES 29
Grand Total 128

Total
120

99
100

80

60
Total
40
29

20

0
NO YES

Fig no. 19
Inference:
77% chemist believes that low cost of generic drugs it does not affects selling &
purchasing of branded drugs.

52
5.4DISTRIBUTORS
DISTRIBUTORS ANALYSIS
Q. 20 - How many chemists visit your stores, Daily?

Table No. 20
20-50 6
50-75 6
75& ABOVE 3
Grand Total 15

Total
7
6 6
6

4
3
3 Total

0
25-50 50-75 75-ABOVE

Fig no. 20

53
Q. 21 – Do you store Generic drug?

Table No. 21
YES 15
NO 0
Grand Total 15

Total
16 15

14

12

10

8
Sales
6

2
0
0
YES NO

Fig no. 21
Inference:
All distributors stores generic drugs.

54
Q. 22 – Do you receive orders for Generic Drugs?

Table No. 22
YES 15
NO 0
Grand Total 15

Total
16 15
14
12
10
8
Total
6
4
2
0
0
YES NO

Fig no. 22
Inference:
All distributors receive orders for generic drugs.

55
Q. 23 - What is the average demand for Generic drugs?

Table No. 23
0-25% 1
25-50% 8
50-75% 5
75-100% 1
Grand Total 15

Total
9
8
8
7
6
5
5
4 Sales
3
2
1 1
1
0
0-25% 25-50% 50-75% 75-100%

Fig no.23

Inference:
25 - 50% average demand for generic drugs.

56
Q. 24 –Do
Do certain doctors purchase Generic drugs?

Table No. 24
NO 2
YES 13
Grand Total 15

Total
14 13

12

10

6 Total

4
2
2

0
NO YES

Fig no. 24

Inference:
86% doctors purchases generic drugs.

57
Q. 25 - Do you suggest doctors or chemist for purchasing Generic drugs?

Table No. 25
NO 4
YES 11
Grand Total 115

Total
12 11

10

6
4 Total
4

0
NO YES

Fig no. 25

Inference:
73% distributors suggest chemist& doctors for purchasing generic drugs.

58
Q. 26 - Does Generic drugs due to their lower prices, affect the sale of brandeddrugs?

Table No. 26
NO 8
YES 7
Grand Total 15

Total
8.2
8
8
7.8
7.6
7.4
7.2 Total
7
7
6.8
6.6
6.4
NO YES

Fig no. 26

Inference:
More than 50% distributors believe that low cost of generic drugs does not affect sale
of Branded drugs.

59
OBSERVATION
&
FINDINGS

60
 6. OBSERVATION &FINDINGS
Physicians say that almost all patients want to talk about the appropriate use of their
medications and cost at least some of the time. Most physicians say they know some
(thing) about the price differences between brand name drugs and generic drugs.
Primary care physicians are twice as likely as medical specialists to say they know a
lot about price differences between brand namedrugs and generic substitutes. Primary
care physicians are more likely than medical specialists to say their patients want
them to prescribe generic drugs and that the price difference is often so great they feel
they must prescribe generics.
Physicians say branded drug representatives visit weekly and give free samples but
generic drug representatives don’t & it doesn’t affect to generic drugs sale.
Primary care physicians are more likely to have an office or clinic based practice, to
see more than 100 patients in a typical week, to see patients of all ages, and to write
more prescriptions ina week than are medical specialists.
82% doctors believe that generic drugs are safe as branded drugs.
73 % doctors allow generic drugs to be substitute for branded drugs

71% doctors feel that generic drugs are not differ from FDA standards.

More than 91% chemist store generic drugs & 86% chemist receive Prescription for
generic drugs weakly.
According to doctors patients can save more than 50% money by taking generic
drugs.

69% doctors feel that Prescription will not affect by free samples which are given by
MR.

According to 53% distributors, average demand for generic drugs is 25 – 50%.

More than 77% chemist & 53% distributors‘ feels that due to low cost of generic
drugs it will not affect sell of branded drugs

61
 SUGGESTIONS/
RECOMMENDATION

62
 7. SUGGESTIONS/RECOMMENDATION
An initiative should be taken to increase awareness about Generic drugs
amongDoctors, chemist & Distributors to increase the Sales of the antibiotic product.

Company should target and promote the Generic Drugs in Government Hospitals as
well as Private hospitals.

Efficacy Safety, Quality, and Availability of product are the important attributes
which should be considered for launching Generic Drugs.

New strategies of reminder aids in increasing sales.

Company should have strong distribution network in market so that Generic Drugs
are available throughout market.

As per the survey, Availability and Affordability are the most important parameters;
hence company should focus on these parameter.

63
CONCLUSION

64
 8. CONCLUSION

From the above analysis it is concluded that doctors, chemists & distributors are
aware about the generic drugs and also they purchase and prescribe Generic drugs to
the patient.

From the comparative analysis between Branded and Generic it is found that price is
the only difference between those drug.

Physicians support generic substitution in most cases and consider them

knowledgeable about generic bioequivalence. In fact, three in four physicians who
said that they allow generic substitutes for branded drugs. However, they also said
that a patient’s needs influence their choice to prescribe brand over generic.

Primary care physicians are more likely than medical specialists to say they support
generic substitution for brand name drugs in most cases, but there are some situations
where it is notappropriate.

65
ANNEXURE

66
 ANNEXURE

QUESTIONNAIRE FOR DOCTOR

Name of Doctor__________________ Specialisation____________________________

Name of Hospital: __________________Qualification:_________________________

Q.1 - Do you believe that Generic drugs differ from FDA standards?
a) YES b) NO

Q.2 - Do you allow Generic drugs to be substitute for Branded drugs?

a) YES b) NO

Q.3 - Do Patients need influence choice to prescribe Generic over Branded drugs?
a) YES b) NO

Q.4 - Do you agree that Branded drug Companies are benefitted by givingpatients with,
Branded drugs than Generic drugs?
a) YES b) NO

Q.5 - Do you feel patients are pressured with health care plan, By Insurance companies
toTake Generic drugs?
a) YES b) NO

Q.6 - Branded drugs MR visit regularly and give free samples but Generic
drugsrepresentative do not give, so is it affects to Prescription?
a) YES b) NO
Q.7 - According to you, are Generic drugs as safe and effective as Branded drugs?

67
 a) YES b) NO

Q.8 - How much it will help to the patients to save money, by taking Generic drugs?
a) 10-20% b) 20-30%
c) 30-50% d) above 50 %

Q.9 - Do you purchase or Rx Generic drugs?

a) Prescribe b) Purchase

Q.10 - If you Purchase Generic drugs, then how frequently you purchase?
a) Regularly b) ˃ 3 months
c) ˃ 6 months d) ˃ 9 months
e) ˃ 1year

Q.12 - Any suggestion?

Date: Sign:

68
 QUESTIONNAIRE FOR CHEMIST

Name of Chemist : ___________________Qualification:_________________________

Name of Hospital:____________________________

Q.1 - How many patients does visit your stores, Daily?

a) 0-25b) 25-50
c) 50-75 d) 75 and above

Q.2 - Do you store Generic drugs?

a) YES b) NO

Q.3 - Do you receive Prescriptions for Generic drugs?

a) YES b) NO

Q.4 - If yes, then how many prescriptions of Generic drugs you receive, weakly?
a) 0-20% b) 20-40%
c) 40-60% d) 60 and above

Q.5 - Do you get discount on purchasing Generic drugs from distributors?

a) YES b) NO

Q.6 - If yes, how much of discount you get from distributors on purchasing Generic
drugs?
a) 0-5% b) 5-10%
c) 10-15% d) 15-20%

69
Q.7 - Is there any effect of taxation on purchasing & selling Generic drugs?
a) YES b) NO

Q.8 - Does Generic drugs due to their lower prices, affects the Sell of branded drugs?
a) YES b) NO

Q.9 - Any suggestion?

Date: Sign:

70
 QUESTIONNAIRE FOR DISTRIBUTOR

Name of Distributors : ____________________________

Qualification : ___________________________

Q.1 - How many chemists does visit your stores, Daily?

a) 0-25 b) 25-50
c) 50-75 d) 75 and above

Q.2 - Do you store Generic drugs?

a) YES b) NO

Q.3 - Do you receive orders for Generic drugs?

a) YES b) NO

Q.4 – What is the average demand for Generic drugs?

a) 0 - 25% b) 25 - 50%
c) 50 – 75% d) 75 - 100%

Q. 5– Do certain doctors purchase Generic drugs?

a) YES b) NO

Q.6 - Do you suggest to doctors or chemist for purchasing Generic drugs?

a) YES b) NO

Q.7 - Does Generic drugs due to their lower prices, affects the Sell of branded drugs?
a) YES b) NO

71
Q.8 - Any suggestion?

Date: Sign:

72
BIBLIOGRAPHY

73
 BIBLIOGRAPHY

1. BOOKS :-
Research Methodology by C. R. Kothari.(Gerald Milburn Scientific research)
Marketing Management by Phillip Kotler.

2. ANNUAL REPORT:-
Government of India Ministry of Chemicals & Fertilizers Department of
Pharmaceuticals, Annual Report 2016-17

3. JOURNAL:-
International journal of pharmaceutical, chemical and biological sciences

4. WEBLINKS:-

http://www.ukessays.com/essays/international-business/global-
pharmaceutical- industry.php
http://www.pmlive.com/top_pharma_list/global_revenue
http://www.vccircle.com/news/pharmaceuticals/2014/02/17/india%E2%80%9
9s- pharma-sales-reach-27b-2016-deloitte-report
http://www.ibef.org/industry/pharmaceutical-india.aspx
http://www.pharmabiz.com/ArticleDetails.aspx?aid=79940&sid=9
http://www.pharmaceutical-drug-manufacturers.com/articles/top10-
pharmaceuticals- companies-in-india
http://www.ibef.org/industry/pharmaceutical-india.aspx
http://www.pharmabiz.com/ArticleDetails.aspx?aid=79940&sid=9
www.pwc.com/india
http://en.wikipedia.org/wiki/Amravati_district
http://www.who.int/trade/glossary/story034/en/
http://www.fda.gov/downloads/Drug/SmallBusinessAssistance/ucm127615.pd
f

74
 http://www.tevagenerics.com/assets/base/pdf/Savings,AnEconomicAnalysis.p
df
http://www.cci.gov.in/images/media/presentations/ComIssGenPharmIndusInd
ia_20100401142346.pdf
www.ijpcbs.com/ THE IMPORTANCE OF GENERIC DRUGS IN INDIA
INDIAN DRUGS & PHARMACEUTICALS LIMITED w.e.f- 10.01.2013

5. ENCYCLOPEDIA:-
Wikipedia

75
76